------------------------------
OMB APPROVAL
------------------------------
OMB Number
Expires:
Estimated average burden
hours per response ....... 0.5
------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. )(1)
Pharmaceutical Marketing Services
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
717123103
- --------------------------------------------------------------------------------
(CUSIP Number)
Charles A. Nalbone, Bear Stearns & Co. Inc.
115 South Jefferson Road, Whippany, NJ 07981
(973) 973-2202
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 29, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b)
for other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of Pages)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(SC13D-07/98)
<PAGE>
CUSIP No. 717123103 13D Page of Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Bear, Stearns & Co. Inc.
IRS # 13-3299429
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
WC, PF
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
557,209
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 96,888
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 557,209
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
96,888
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
654,097
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.25%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
BD
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 717123103 13D Page of Pages
________________________________________________________________________________
Item 1. Security and Issuer.
Common Stock
Pharmaceutical Marketing Services
45 Rockefeller Plaza
New York, NY 10111
________________________________________________________________________________
Item 2. Identity and Background.
(a)Name: Bear, Stearns & Co. Inc. ("Bear Stearns")
(b)Place of Organization: Delaware
(c)(i)Principal Business: Securities Broker/Dealer
(ii) Address: 245 Park Avenue
New York, NY 10167
(d)None
(e)See Appendix II
(f)See Appendix I
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
Working capital of Bear Stearns and personal funds of discretionary accounts.
The aggregate purchase price of the 654,097 shares of Common Stock was
approximately $9,361,763.
________________________________________________________________________________
Item 4. Purpose of Transaction.
Bear Stearns has acquired the Common Stock of Pharmaceutical Marketing
services in the ordinary course of its business as a broker/dealer in
connection with its trading and investment activities. Bear Stearns may acquire
additional securities of the Issuer or dispose of securities of the Issuer in
connection with such trading and investment activities. Although the foregoing
represents the range of activities presently contemplated by Bear Stearns with
respect to the Issuer, it should be noted that the possible activities of Bear
Stearns are subject to change at any time.
Except as set forth above, Bear Stearns has no present plans or intentions
which relate to or would result in any of the actions described in
subparagraph (a) through (j) of item 4 of Schedule 13D.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer as of 2/26/99.
(a)Number: 654,097
Percentage: 5.25%
(b)1.Sole power to vote or to direct the vote: 557,209
2.Shared power to vote or to direct the vote: 96,888
3.Sole power to dispose or to direct the disposition: 654,097
4.Shared power to dispose or to direct the disposition: 96,888
(c)Information concerning transactions in the common stock effected by
Bear Stearns is set forth on Appendix III hereto.
(d)Inapplicable.
(e)Inapplicable.
________________________________________________________________________________
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None
________________________________________________________________________________
Item 7. Material to be Filed as Exhibits.
None
________________________________________________________________________________
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
April 7, 1999
----------------------------------------
(Date)
----------------------------------------
(Signature)
Barry J. Cohen/Senior Managing Director
----------------------------------------
(Name/Title)
APPENDIX I
DIRECTORS AND EXECUTIVE OFFICERS OF BEAR, STEARNS & CO. INC.
Name Principal Occupation or Employment
Alan C. Greenberg Chairman of the Board and Director
James E. Cayne President, Chief Executive Officer and Director
Alan D. Schwartz Executive Vice President and Director
Warren J. Spector Executive Vice President and Director
Michael L. Tarnopol Executive Vice President and Director
John L. Knight Director
John H. Slade Director Emeritus
Kenneth L. Edlow Secretary
William J. Montgoris Chief Operating Officer
Michael J. Abatemarco Controller and Assistant Secretary
Michael Minikes Treasurer
Frederick B. Casey Assistant Treasurer
Mark E. Lehman Executive Vice President-General Counsel and Director
Samuel L. Molinaro, Jr. Chief Financial Officer
John L. Knight is a citizen of the United Kingdom and his business address is
One Canada Square London E16 5AD England. Michael J. Abatemarco is a citizen of
the United States and his business address is One Metrotech Center North,
Brooklyn, New York 11201. All other Directors and Executive Officers are
citizens of the United States and their business address is 245 Park Avenue,
New York, New York 10167. Bear Stearns & Co. Inc. is a wholly-owned subsidiary
of the Bear Stearns Companies Inc. and of the persons named, all but John L.
Knight hold similar office in the parent company.
APPENDIX II
Bear Stearns & Co. Inc.
Pharmaceutical Marketing Services
Trading from 1/19/99 through 3/29/99
(Various Firm's Accounts)
***** 03/29 *****
100 PHARMACEUTICAL MARKETING 14 15/16 1,493.75
SERVICES INC
100 PHARMACEUTICAL MARKETING 15 1,500.00
SERVICES INC
100 PHARMACEUTICAL MARKETING 15 1/4 1,525.00
SERVICES INC
200 PHARMACEUTICAL MARKETING 15 3,000.00
SERVICES INC
200 PHARMACEUTICAL MARKETING 15 3,000.00
SERVICES INC
200 PHARMACEUTICAL MARKETING 15 1/16 3,012.50
SERVICES INC
200 PHARMACEUTICAL MARKETING 15 3/16 3,037.50
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 3/4 7,375.00
SERVICES INC
600 PHARMACEUTICAL MARKETING 14 15/16 8,962.50
SERVICES INC
600 PHARMACEUTICAL MARKETING 15 3/16 9,112.50
SERVICES INC
700 PHARMACEUTICAL MARKETING 14 7/8 10,412.50
SERVICES INC
700 PHARMACEUTICAL MARKETING 15 10,500.00
SERVICES INC
700 PHARMACEUTICAL MARKETING 15 1/8 10,587.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 7/8 14,875.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 15 15,000.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 15 1/16 15,062.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 15 1/8 15,125.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 15 1/4 15,250.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 13/16 14,812.50
SERVICES INC
1,100 PHARMACEUTICAL MARKETING 15 16,500.00
SERVICES INC
1,200 PHARMACEUTICAL MARKETING 15 1/8 18,150.00
SERVICES INC
1,300 PHARMACEUTICAL MARKETING 14 7/8 19,337.50
SERVICES INC
1,400 PHARMACEUTICAL MARKETING 14 15/16 20,912.50
SERVICES INC
1,500 PHARMACEUTICAL MARKETING 15 3/16 22,781.25
SERVICES INC
1,600 PHARMACEUTICAL MARKETING 15 24,000.00
SERVICES INC
1,900 PHARMACEUTICAL MARKETING 14 7/8 28,262.50
SERVICES INC
2,000 PHARMACEUTICAL MARKETING 15 30,000.00
SERVICES INC
2,600 PHARMACEUTICAL MARKETING 15 3/16 39,487.50
SERVICES INC
2,700 PHARMACEUTICAL MARKETING 14 15/16 40,331.25
SERVICES INC
2,800 PHARMACEUTICAL MARKETING 15 1/8 42,350.00
SERVICES INC
3,000 PHARMACEUTICAL MARKETING 14 7/8 44,625.00
SERVICES INC
4,500 PHARMACEUTICAL MARKETING 15 67,500.00
SERVICES INC
4,800 PHARMACEUTICAL MARKETING 15 1/4 73,200.00
SERVICES INC
5,000 PHARMACEUTICAL MARKETING 15 75,000.00
SERVICES INC
5,000 PHARMACEUTICAL MARKETING 15 75,000.00
SERVICES INC
5,000 PHARMACEUTICAL MARKETING 14 15/16 74,687.50
SERVICES INC
7,100 PHARMACEUTICAL MARKETING 15 106,500.00
SERVICES INC
8,000 PHARMACEUTICAL MARKETING 15 120,000.00
SERVICES INC
8,600 PHARMACEUTICAL MARKETING 15 1/4 131,150.00
SERVICES INC
26,300 PHARMACEUTICAL MARKETING 15 394,500.00
SERVICES INC
9,500 PHARMACEUTICAL MARKETING 15 1/4 144,875.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 15.2150 7,607.50
SERVICES INC
700 PHARMACEUTICAL MARKETING 14 7/8 10,412.50
SERVICES INC
2,000 PHARMACEUTICAL MARKETING 14 15/16 29,875.00
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 14 9/16 14,562.01-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 14 11/16 14,687.01-
SERVICES INC
***** 03/25 *****
4,600 PHARMACEUTICAL MARKETING 13 7/8 63,825.00
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 15/16 13,937.03-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 15/16 13,937.03-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 15/16 13,937.03-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 14 1/16 14,062.03-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 15/16 13,937.03-
SERVICES INC
1,600- PHARMACEUTICAL MARKETING 13 15/16 22,299.25-
SERVICES INC
***** 03/24 *****
18,594 PHARMACEUTICAL MARKETING 13.4930 250,888.84
SERVICES INC
100- PHARMACEUTICAL MARKETING 13 3/8 1,337.45-
SERVICES INC
100- PHARMACEUTICAL MARKETING 13 9/16 1,356.20-
SERVICES INC
100- PHARMACEUTICAL MARKETING 13 1/2 1,349.95-
SERVICES INC
500- PHARMACEUTICAL MARKETING 13 9/16 6,781.02-
SERVICES INC
800- PHARMACEUTICAL MARKETING 13 1/4 10,599.64-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 7/16 13,437.05-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 3/8 13,374.55-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 5/8 13,624.54-
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 13 7/16 13,437.05-
SERVICES INC
1,200- PHARMACEUTICAL MARKETING 13 1/4 15,899.47-
SERVICES INC
1,500- PHARMACEUTICAL MARKETING 13 7/16 20,155.57-
SERVICES INC
1,700- PHARMACEUTICAL MARKETING 13 1/4 22,524.24-
SERVICES INC
2,000- PHARMACEUTICAL MARKETING 13 3/8 26,749.10-
SERVICES INC
2,600- PHARMACEUTICAL MARKETING 13 3/8 34,773.84-
SERVICES INC
2,600- PHARMACEUTICAL MARKETING 13 1/2 35,098.83-
SERVICES INC
5,000- PHARMACEUTICAL MARKETING 13 5/8 68,122.72-
SERVICES INC
5,000- PHARMACEUTICAL MARKETING 13 1/2 67,497.75-
SERVICES INC
***** 03/23 *****
8,500- PHARMACEUTICAL MARKETING 14.2265 120,921.21-
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 13 3/16 13,187.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 13 13/16 13,812.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 13 7/16 13,437.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 13 5/16 13,312.50
SERVICES INC
10,000 PHARMACEUTICAL MARKETING 13 3/4 137,500.00
SERVICES INC
100- PHARMACEUTICAL MARKETING 13 3/4 1,374.95-
SERVICES INC
100- PHARMACEUTICAL MARKETING 13 3/4 1,374.95-
SERVICES INC
400- PHARMACEUTICAL MARKETING 13 9/16 5,424.81-
SERVICES INC
900- PHARMACEUTICAL MARKETING 13 9/16 12,205.84-
SERVICES INC
1,500- PHARMACEUTICAL MARKETING 13 9/16 20,343.07-
SERVICES INC
4,000- PHARMACEUTICAL MARKETING 13 5/8 54,498.18-
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 3/16 7,093.75
SERVICES INC
1,600 PHARMACEUTICAL MARKETING 14 1/8 22,600.00
SERVICES INC
2,000 PHARMACEUTICAL MARKETING 14 3/16 28,375.00
SERVICES INC
4,400 PHARMACEUTICAL MARKETING 14 1/8 62,150.00
SERVICES INC
***** 03/19 *****
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,000- PHARMACEUTICAL MARKETING 14 1/4 14,249.52-
SERVICES INC
***** 03/16 *****
400- PHARMACEUTICAL MARKETING 14 11/16 5,874.80-
SERVICES INC
***** 03/15 *****
500 PHARMACEUTICAL MARKETING 14 3/16 7,093.75
SERVICES INC
***** 03/12 *****
1,000 PHARMACEUTICAL MARKETING 13 7/8 13,875.00
SERVICES INC
***** 03/03 *****
100 PHARMACEUTICAL MARKETING 13 15/16 1,393.75
SERVICES INC
***** 03/01 *****
100 PHARMACEUTICAL MARKETING 13 15/16 1,393.75
SERVICES INC
***** 02/18 *****
500 PHARMACEUTICAL MARKETING 14 3/8 7,187.50
SERVICES INC
1,400 PHARMACEUTICAL MARKETING 14 3/8 20,125.00
SERVICES INC
8,600 PHARMACEUTICAL MARKETING 14 3/8 123,625.00
SERVICES INC
25,000 PHARMACEUTICAL MARKETING 14 3/8 359,375.00
SERVICES INC
***** 02/17 *****
10,000 PHARMACEUTICAL MARKETING 14 3/8 143,750.00
SERVICES INC
10,000 PHARMACEUTICAL MARKETING 14 3/8 143,750.00
SERVICES INC
25,000 PHARMACEUTICAL MARKETING 14 3/8 359,375.00
SERVICES INC
***** 02/16 *****
1,000 PHARMACEUTICAL MARKETING 14 3/8 14,375.00
SERVICES INC
***** 02/12 *****
10,000 PHARMACEUTICAL MARKETING 14 1/2 145,000.00
SERVICES INC
***** 02/11 *****
100 PHARMACEUTICAL MARKETING 14 3/8 1,437.50
SERVICES INC
100 PHARMACEUTICAL MARKETING 14 3/8 1,437.50
SERVICES INC
200 PHARMACEUTICAL MARKETING 14 7/16 2,887.50
SERVICES INC
400 PHARMACEUTICAL MARKETING 14 3/8 5,750.00
SERVICES INC
400 PHARMACEUTICAL MARKETING 14 7/16 5,775.00
SERVICES INC
400 PHARMACEUTICAL MARKETING 14 7/16 5,775.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 7/16 7,218.75
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 7/16 7,218.75
SERVICES INC
600 PHARMACEUTICAL MARKETING 14 7/16 8,662.50
SERVICES INC
600 PHARMACEUTICAL MARKETING 14 7/16 8,662.50
SERVICES INC
900 PHARMACEUTICAL MARKETING 14 3/8 12,937.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 7/16 14,437.50
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 7/16 14,437.50
SERVICES INC
1,100 PHARMACEUTICAL MARKETING 14 7/16 15,881.25
SERVICES INC
1,200 PHARMACEUTICAL MARKETING 14 7/16 17,325.00
SERVICES INC
1,300 PHARMACEUTICAL MARKETING 14 7/16 18,768.75
SERVICES INC
2,200 PHARMACEUTICAL MARKETING 14 7/16 31,762.50
SERVICES INC
2,700 PHARMACEUTICAL MARKETING 14 7/16 38,981.25
SERVICES INC
3,000 PHARMACEUTICAL MARKETING 14 7/16 43,312.50
SERVICES INC
7,000 PHARMACEUTICAL MARKETING 14 7/16 101,062.50
SERVICES INC
8,800- PHARMACEUTICAL MARKETING 14 7/16 127,045.76-
SERVICES INC
***** 02/03 *****
500 PHARMACEUTICAL MARKETING 14 1/2 7,250.00
SERVICES INC
1,800 PHARMACEUTICAL MARKETING 14 1/2 26,100.00
SERVICES INC
3,000 PHARMACEUTICAL MARKETING 14 1/2 43,500.00
SERVICES INC
***** 01/22 *****
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,400 PHARMACEUTICAL MARKETING 14 1/4 19,950.00
SERVICES INC
5,000 PHARMACEUTICAL MARKETING 14 1/4 71,250.00
SERVICES INC
***** 01/22 *****
5,000- PHARMACEUTICAL MARKETING 14 1/4 71,247.62-
SERVICES INC
***** 01/21 *****
100 PHARMACEUTICAL MARKETING 14 1/4 1,425.00
SERVICES INC
700 PHARMACEUTICAL MARKETING 14 1/4 9,975.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,800 PHARMACEUTICAL MARKETING 14 1/4 25,650.00
SERVICES INC
8,200 PHARMACEUTICAL MARKETING 14 1/4 116,850.00
SERVICES INC
***** 01/20 *****
500 PHARMACEUTICAL MARKETING 14 1/4 7,125.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 1/4 7,125.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 1/4 7,125.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 1/4 7,125.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
1,200 PHARMACEUTICAL MARKETING 14 1/4 17,100.00
SERVICES INC
1,800 PHARMACEUTICAL MARKETING 14 1/4 25,650.00
SERVICES INC
2,000 PHARMACEUTICAL MARKETING 14 7/32 28,437.50
SERVICES INC
2,000 PHARMACEUTICAL MARKETING 14 1/4 28,500.00
SERVICES INC
4,000 PHARMACEUTICAL MARKETING 14 1/4 57,000.00
SERVICES INC
4,500 PHARMACEUTICAL MARKETING 14 1/4 64,125.00
SERVICES INC
5,000 PHARMACEUTICAL MARKETING 14 1/4 71,250.00
SERVICES INC
6,500- PHARMACEUTICAL MARKETING 14 1/4 92,621.91-
SERVICES INC
***** 01/19 *****
200 PHARMACEUTICAL MARKETING 14 1/4 2,850.00
SERVICES INC
300 PHARMACEUTICAL MARKETING 14 1/4 4,275.00
SERVICES INC
300 PHARMACEUTICAL MARKETING 14 1/4 4,275.00
SERVICES INC
500 PHARMACEUTICAL MARKETING 14 5/16 7,156.25
SERVICES INC
1,000 PHARMACEUTICAL MARKETING 14 1/4 14,250.00
SERVICES INC
(Various Discretionary Accounts)
***** 02/11 *****
1,880 PHARMACEUTICAL MARKETING 14 7/16 27,142.50
SERVICES INC
***** 02/11 *****
2,408 PHARMACEUTICAL MARKETING 14 7/16 34,765.50
SERVICES INC
4,512 PHARMACEUTICAL MARKETING 14 7/16 65,142.00
SERVICES INC
***** 01/22 *****
1,682 PHARMACEUTICAL MARKETING 14 1/4 23,968.50
SERVICES INC
3,318 PHARMACEUTICAL MARKETING 14 1/4 47,281.50
SERVICES INC
***** 01/21 *****
928 PHARMACEUTICAL MARKETING 14 1/4 13,224.00
SERVICES INC
946 PHARMACEUTICAL MARKETING 14 1/4 13,480.50
SERVICES INC
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
